logo
Select company
Select metric
-0.22%Buyback Yield
VS
Market
34
Sector
66
Industry
80
History
92
$ 12.64Close
$ 5.31 - $ 12.64 52-Week Range
Ticker Information

Ticker

RGNX

Company Name

REGENXBIO INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

REGENXBIO INC - Buyback Yield Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

RGNX - Buyback Yield Historical data
DateBuyback YieldMarket CapitalizationNet Cash Flow - Issuance (Purchase) of Equity Shares
6/30/2025-0.22%$ 399.06M$ 884K
3/31/2025-0.22%$ 399.78M$ 861K
12/31/2024-40.68%$ 328.06M$ 133.45M
9/30/2024-28.67%$ 467.21M$ 133.94M
6/30/2024-21.17%$ 657.82M$ 139.26M
3/31/2024-17.06%$ 821.1M$ 140.06M
12/31/2023-0.92%$ 889.44M$ 8.22M
9/30/2023-1.12%$ 721.91M$ 8.05M
6/30/2023-0.47%$ 830.85M$ 3.88M
3/31/2023-0.53%$ 879.32M$ 4.64M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • REGENXBIO INC's latest trailing twelve months (TTM) Buyback Yield stands at -0.65%.
  • Over the past 5 years, REGENXBIO INC's average Buyback Yield has been -9%.
  • The median Buyback Yield for REGENXBIO INC during this period was -0.79%
  • REGENXBIO INC reached its highest Buyback Yield over the past 5 years at -0.22%.
  • The lowest Buyback Yield recorded by REGENXBIO INC in the same timeframe -40.68%

REGENXBIO INC's Buyback Yield vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Buyback Yield Benchmarks
CompanyBuyback Yield
CTMX : CYTOMX THERAPEUTICS INC -27.66%XNCR : XENCOR INC -39.31%ARCT : ARCTURUS THERAPEUTICS HOLDINGS INC -0.42%YMAB : Y-MABS THERAPEUTICS INC -0.62%GLUE : MONTE ROSA THERAPEUTICS INC -0.38%HRTX : HERON THERAPEUTICS INC -0.63%NKTR : NEKTAR THERAPEUTICS -0.07%PACB : PACIFIC BIOSCIENCES OF CALIFORNIA INC -0.73%LXRX : LEXICON PHARMACEUTICALS INC 0.01%VNDA : VANDA PHARMACEUTICALS INC 0%

Definition of Buyback Yield

[Calculation] The Buyback Yield is a ratio that calculates the difference between the trailing twelve-month share issuances and repurchases [NCFCommon] and divides it by the [MarketCap] of the company. A negative value indicates a dilution of shareholder value and might be considered as a warning sign.
(-1 * CF - Equity) / Market Cap
(=) Buyback Yield
Buyback Yield for REGENXBIO INC is calculated as follows: (-1 * CF - Equity [ $ 7.59M ]) / Market Cap [ $ 1.16B ]
(=) Buyback Yield [ -0.65% ]

RGNX - Buyback Yield, Last 5 years

-40.68%

Minimum

Dec 31, 2024

-0.22%

Maximum

Mar 31, 2025

-9%

Average

-0.79%

Median

Buyback Yield Benchmark Analysis

The chart above depicts the distribution of Buyback Yield for companies in the Total Stock Market. The average Buyback Yield of the companies is 0.64% with a standard deviation of 2.71%.
The following table provides additional summary stats:
Buyback Yield in the Market:
filtered constituents3.28K
min-8.43%
max8.46%
average0.64%
median0.01%
std2.71%